Current scenario of indole-azole hybrids with anticancer potential: part II. Imidazole, oxadiazole, oxazole, and isoxazole hybrids.

Indole derivatives have emerged as a "privileged pharmacophore" in cancer therapy, owing to their inherent structural flexibility, low intrinsic toxicity, and high binding affinity for oncogenic targets. Indole moiety readily accommodates functional…

Preview only. Read the full abstract at the source